Skip to search.
 TSX Up 0.03% TSX Ventures Up 1.56%

Biogen Inc. (BIIB)

-NasdaqGS
306.85 Down 2.48(0.80%) 4:00PM EDT
|After Hours : 306.85 0.00 (0.00%) 5:23PM EDT - Nasdaq Real Time Price
Prev Close:309.33
Open:309.03
Bid:306.90 x 3900
Ask:307.27 x 100
1y Target Est:340.33
Beta:0.433028
Earnings Date:Oct 19 - Oct 24 (Est.)
Day's Range:301.02 - 311.97
52wk Range:223.02 - 333.65
Volume:1,665,812
Avg Vol (3m):2,103,600
Market Cap:67.24B
P/E (ttm):17.92
EPS (ttm):17.12
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
BIIBDown 0.80%67.24B
PFEDown 0.14%210.90B
ABTDown 0.76%62.97B

Key Statistics

Forward P/E (1 yr):14.70
P/S (ttm):6.03
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :20.11
Quarterly EPS Est (Sep-16) :5.02
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):1.62

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Biogen Inc. discovers, develops, manufactures, and delivers therapies for the treatment of neurodegenerative diseases, hematologic conditions, and autoimmune disorders. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback